EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, MAY 18, 2020
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2020.0756?guestAccessKey=d6223806-b43a-4dfc-8626-c8c4b8c373fc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051820
What The Study Did: Following an outbreak of electronic cigarette or vaping product use–associated lung injury (EVALI) linked to hospitalizations and deaths, this study used data reported to the Centers for Disease Control and Prevention to compare demographic and clinical characteristics, along with substance use behaviors, between adolescents and adults with EVALI.
Authors: Susan H. Adkins, M.D., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.
# # #
For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.